ATE182788T1 - Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie - Google Patents

Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie

Info

Publication number
ATE182788T1
ATE182788T1 AT96931199T AT96931199T ATE182788T1 AT E182788 T1 ATE182788 T1 AT E182788T1 AT 96931199 T AT96931199 T AT 96931199T AT 96931199 T AT96931199 T AT 96931199T AT E182788 T1 ATE182788 T1 AT E182788T1
Authority
AT
Austria
Prior art keywords
neurogenic inflammation
gene therapy
receptor antagonists
receptor
neurogenic
Prior art date
Application number
AT96931199T
Other languages
English (en)
Inventor
Giovanni Piedimonte
Hans J Hess
John A Lowe Iii
Original Assignee
Pfizer
Giovanni Piedimonte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Giovanni Piedimonte filed Critical Pfizer
Application granted granted Critical
Publication of ATE182788T1 publication Critical patent/ATE182788T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96931199T 1995-10-10 1996-10-02 Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie ATE182788T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US500295P 1995-10-10 1995-10-10
US634495P 1995-11-07 1995-11-07

Publications (1)

Publication Number Publication Date
ATE182788T1 true ATE182788T1 (de) 1999-08-15

Family

ID=26673771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96931199T ATE182788T1 (de) 1995-10-10 1996-10-02 Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie

Country Status (9)

Country Link
US (1) US6562335B1 (de)
EP (1) EP0854720B1 (de)
JP (1) JP3041051B2 (de)
AT (1) ATE182788T1 (de)
CA (1) CA2228572C (de)
DE (1) DE69603615T2 (de)
ES (1) ES2134639T3 (de)
GR (1) GR3031758T3 (de)
WO (1) WO1997013514A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1067051C (zh) * 1998-06-05 2001-06-13 中国科学院广州化学研究所 一种制备桥环二元酸酐二酯的方法
NZ524673A (en) * 2000-09-26 2005-08-26 Tanabe Seiyaku Co 5-phenylbenzylamine compounds, process for preparing the same and synthetic intermediates thereof
EP2117538A1 (de) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmazeutische zusammensetzungen mit 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI990419A7 (fi) 1991-06-20 1999-02-26 Pfizer Typpeä sisältävien hetrosyklisten yhdisteiden fluorialkoksibentsyyliaminojohdannaiset
US6048859A (en) * 1992-06-29 2000-04-11 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
WO1994026735A1 (en) 1993-05-06 1994-11-24 Merrell Dow Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
AU7082194A (en) * 1993-09-17 1995-04-03 Pfizer Inc. Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
US5872154A (en) * 1995-02-24 1999-02-16 The Trustees Of The University Of Pennsylvania Method of reducing an immune response to a recombinant adenovirus
US5993800A (en) * 1995-06-05 1999-11-30 Bristol-Myers Squibb Company Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand

Also Published As

Publication number Publication date
CA2228572C (en) 2003-07-22
CA2228572A1 (en) 1997-04-17
JPH10511119A (ja) 1998-10-27
EP0854720A1 (de) 1998-07-29
GR3031758T3 (en) 2000-02-29
JP3041051B2 (ja) 2000-05-15
WO1997013514A1 (en) 1997-04-17
ES2134639T3 (es) 1999-10-01
US6562335B1 (en) 2003-05-13
DE69603615D1 (de) 1999-09-09
DE69603615T2 (de) 2000-02-17
EP0854720B1 (de) 1999-08-04

Similar Documents

Publication Publication Date Title
MX9708780A (es) Nuevos heterociclos como inhibidores de la adhesion de leucocitos y antagonistas de vla-4.
YU49094B (sh) Postupak za dobijanje sinergističke terapeutske kompozicije
UA27776C2 (uk) Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
TR199900326T2 (xx) �st solunum yollar� alerjik tepkisinin histamin resept�r antagonistlerin bir birle�imi ile tedavisi.
PT800519E (pt) Compostos moduladores de receptores de esteroides e metodos
ES2108120T3 (es) Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf.
EA200000080A1 (ru) 1-аминоалкилциклогексановые антагонисты рецепторов nmda
MY118313A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
MY116002A (en) Nk-1 receptor antagonists and 5ht3 receptor antagonists for the treatment of emesis
DE69419623D1 (de) Peptidinhibitoren der urokinaserezeptor-aktivität
ES2091877T3 (es) Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia.
FI954609A0 (fi) 1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
ATE170845T1 (de) Plättchenaggregationsinhibitoren
NO963064D0 (no) Behandling av normotensive glaukoma med angiotensin-II-antagonister
DE69433058D1 (de) Neuartige peptidantagonisten der glutaminsäure- und nmda-rezeptoren
ES2196898T3 (es) Antagonistas de receptores de crf y metodos relacionados.
ATE211737T1 (de) Tricyclisch substituierte 2,4-dithi(oxo)- pyrimidin-5-yl-verbindungen als p2- purinoceptor- antagonisten
DE69330754D1 (de) 2,5-DIOXO-2,5-DIHYDRO-1H-BENZ[b]AZEPINE ALS NMDA REZEPTOR ANTAGONISTEN
DK0659193T3 (da) Blodpladeaggregationsinhibitorer
ATE182788T1 (de) Nk-1 rezeptor antagonisten in neurogener entzündung in gen-therapie
CA2152401A1 (fr) Association synergisante ayant un effet antagoniste des recepteurs nk1 et nk2
ATE235468T1 (de) Plättchenaggregationsinhibitoren
ES2156444T3 (es) Nuevos compuestos.
NO20001548D0 (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee